Two institutional investors sold more than $860 million worth of stock in Iqvia Holdings Inc. stock on Nov. 30, according to two separate filings earlier this week with the Securities and Exchange Commission.
Bain Capital Investors sold 1,163,191 shares at an average price of $102 per share for a total transaction of $118,645,482.
Iqvia shares traded at just above $101 on Wednesday afternoon.
Bain managing director John Connaughton has served as a director of Iqvia since October 2016. He previously served as a director of Quintiles since 2008.
Bain Capital also sold 1,030,429 shares of Iqvia stock on Sept. 19 at an average price of $94.87 for a transaction of roughly $97,756,799.
CPP Investment Board Private Holdings Inc. sold 7,497,807 shares on Nov. 30 at an average price of $102 per share for a total transaction of $764,776,314.
The CPP Investment Board invests funds of the Canada Pension Plan for its 20 million Canadian contributors and beneficiaries.
The Toronto-based investment board has the singular objective to maximize returns without undue risk of loss by capitalizing on its comparative advantages.
CPPIB also sold shares of Iqvia stock on Sept. 19 totaling roughly $640,185,226 with the sale of 6,748,026 shares.
Iqvia, formerly Quintiles IMS Holdings Inc., is a multinational human data science company. It has one of its main offices in the Research Triangle Park.
Note: This story is from the North Carolina Business News Wire, a service of UNC-Chapel Hill’s School of Media and Journalism.
